We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current SRRK market cap is 963.11M. The company's latest EPS is USD -2.2981 and P/E is -5.81.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -40.43M | -40.51M | -39.08M | -43.67M | -48.03M |
| Net Income | -39.26M | -39.38M | -37.93M | -42.36M | -46.13M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 20.49M | 15.4M | 18.82M | 33.19M | 0 |
| Operating Income | -54.54M | -86.88M | -129.92M | -134.37M | -171.3M |
| Net Income | -51M | -86.48M | -131.8M | -134.5M | -165.79M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 358.17M | 314.72M | 284.9M | 250.69M | 311.04M |
| Total Liabilities | 97.93M | 86.07M | 82.4M | 83.02M | 85.82M |
| Total Equity | 260.24M | 228.65M | 202.5M | 167.67M | 225.22M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 196.38M | 388.31M | 304.45M | 358.17M | 311.04M |
| Total Liabilities | 83.48M | 127.54M | 132.37M | 97.93M | 85.82M |
| Total Equity | 112.9M | 260.77M | 172.07M | 260.24M | 225.22M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -132.69M | -43.05M | -75.6M | -107.88M | -145.23M |
| Investing | -171.7M | 89.98M | 74.74M | 66.27M | 41.14M |
| Financing | 194.83M | 1.08M | 5.77M | 6.05M | 102.57M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -63.12M | -60.27M | -126.79M | -132.69M | -145.23M |
| Investing | -62.24M | -63.5M | 134.32M | -171.7M | 41.14M |
| Financing | 48.88M | 247.82M | 44.95M | 194.83M | 102.57M |
| Market Cap | 963.11M |
| Price to Earnings Ratio | -5.81 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 9.46 |
| Price to Book Ratio | 4.28 |
| Dividend Yield | - |
| Shares Outstanding | 72.14M |
| Average Volume (1 week) | 636.79k |
| Average Volume (1 Month) | 658.42k |
| 52 Week Change | 55.23% |
| 52 Week High | 21.17 |
| 52 Week Low | 5.56 |
| Spread (Intraday) | 5.11 (35.83%) |
| Company Name | Scholar Rock Holdings Corporation |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.scholarrock.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
